Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): Signs, Risks, and Emergency Care

The Spectrum of Severity: SJS vs. TEN

Medical professionals view these two conditions not as different diseases, but as points on the same spectrum of severity. The main difference is how much of your body is affected. If less than 10% of your skin surface is involved, it's classified as Stevens-Johnson Syndrome. When the damage covers 10% to 30%, it's called an overlap syndrome. Once more than 30% of the body surface area is affected, it is diagnosed as Toxic Epidermal Necrolysis (TEN), which is the most severe form of severe cutaneous adverse reactions (SCAR).

In the most extreme cases of TEN, nearly 100% of the skin can slough off, leaving the body without its primary barrier against infection. This is why patients are often moved to specialized burn units or intensive care units (ICU), as the care required is similar to that of a severe thermal burn patient.

Spotting the Warning Signs Early

The danger of SJS and TEN is that they don't start with skin peeling. They start with "prodromal" symptoms that are easy to mistake for a common cold or the flu. You might experience fever, malaise, and a sore throat. Within one to three days, the skin changes begin. A rapidly spreading rash appears, usually accompanied by the involvement of at least two mucosal sites-meaning the membranes lining your mouth, eyes, or genitals.

Common early indicators include:

• Blisters forming on the lips or inside the cheeks.
• Extreme redness and irritation in the eyes (conjunctivitis).
• Painful sores in the genital area.
• A "dusky" red or purple rash that feels tender to the touch.

If you notice these symptoms after starting a new medication, do not wait for the rash to spread. Go to the emergency room immediately. Early intervention is the only way to significantly lower mortality rates, which can climb above 30% for those with full-blown TEN.

High-Risk Medications and Triggers

While these reactions are rare, they are most often caused by specific types of drugs. It's not just about the drug itself, but sometimes how it's introduced to the body. For example, with certain epilepsy medications, increasing the dose too quickly can trigger the reaction.

It is also vital to understand cross-reactivity. If you have had a reaction to one anticonvulsant, your body might react similarly to another one because they share a similar chemical structure. This means survivors must be extremely careful and avoid not only the trigger drug but entire classes of related medicines.

Who Is Most at Risk?

Not everyone who takes these drugs will develop SJS or TEN, but certain factors can tip the scales. Genetic predisposition plays a huge role; if a close family member has had this condition, your risk increases. Additionally, people with compromised immune systems-such as those living with HIV/AIDS or those undergoing chemotherapy-are more susceptible.

There are also specific drug-drug interactions to watch for. For instance, taking sodium valproate at the same time as lamotrigine can increase the likelihood of a severe skin rash. Similarly, people who have already shown an allergy to trimethoprim may be more likely to experience these reactions.

The Road to Recovery and Long-Term Complications

Surviving the initial acute phase of SJS/TEN is the first hurdle, but the recovery process is long. Because the skin and mucous membranes are destroyed, the body often replaces them with scar tissue, which doesn't function as well as the original tissue.

The most concerning long-term issues often happen in the eyes. Between 30% and 50% of survivors face serious ocular complications, including corneal scarring, severe dry eye, and in some cases, total blindness. This is why follow-up care with an ophthalmologist for at least one year is mandatory.

Other lasting effects include:

• Skin Changes: Permanent depigmentation or deep cutaneous scarring.
• Hair and Nails: Diffuse thinning of scalp hair and nail dystrophy (though nails often recover).
• Internal Scarring: Esophageal strictures (narrowing of the throat) or vulvovaginal stenosis in women and phimosis in men.

How to Prevent a Recurrence

Once you have had SJS or TEN, your immune system is essentially "primed" to attack that specific drug. Re-exposure, even in a tiny dose, can cause a faster and more severe recurrence. The most effective prevention is total avoidance. You should carry a medical alert bracelet or a card in your wallet listing the offending medication and its chemical class.

For those starting high-risk medications like lamotrigine, doctors recommend a very slow dose titration. Some clinicians advise avoiding new foods or other new medicines during the first three months of treatment to ensure that any rash that appears can be clearly linked to the primary medication without confusion.

Next Steps for Patients and Caregivers

If you are currently taking a medication listed as high-risk, the best thing you can do is educate yourself on the early signs. Keep a log of when you start a new dose and monitor for any "flu-like" symptoms. If you are a survivor, your priority is the long-term multidisciplinary team. You will likely need regular check-ups with a dermatologist for skin grafting or scar management, and an ophthalmologist to prevent permanent vision loss.

For those managing chronic conditions with these drugs, remember that a small rash isn't always a disaster-many people get mild rashes that resolve on their own. However, the moment that rash involves the eyes, mouth, or begins to blister, it is no longer a "mild rash." It is time to seek emergency care.